aafp glp 1 Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Glucagon-Like Peptide-1 Receptor Agonists for

doi: 10.3389/FBIOE.2020.00910 141 RaiM.WypijM.IngleA

Conflicts of Interest The authors declare no conflicts of interest

Ann Thorac Surg 105(6):1621-1626, 2018

McNeil has engineered safety packaging and spent millions on research, education and poison control centers that advise people who have overdosed

Data analysis The data relating to pain, disease progression, need for surgery and side effects were compared before and 6 months after therapy using the chi-square test

Morgan Stanley also speculates that ziltivekimab could reach annual sales of USD 5 billion if the drug proves effective in other indications as well